Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.63 |
| ▸ | CA1 | P00915 | 4/20 | 0.63 |
| ▸ | CA6 | P23280 | 4/20 | 0.63 |
| ▸ | CA7 | P43166 | 4/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.63 |
| ▸ | CA4 | P22748 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.63 |
| ▸ | CA3 | P07451 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.60 |
| ▸ | GLA | P06280 | 4/20 | 0.60 |
| ▸ | GAA | P10253 | 4/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | CA5A | P35218 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4293165 | 1.00 | CA12 (0.63) | CA12CA9CA1CA6CA7 | |
| SCHEMBL19831442 | 1.00 | CA12 (0.63) | CA12CA9CA1CA6CA7 | |
| SCHEMBL21043916 | 0.99 | CA12 (0.64) | CA12CA9CA1CA6CA7 | |
| SCHEMBL3469861 | 0.95 | CA12 (0.66) | CA12CA9CA1CA6CA7 | |
| SCHEMBL28061786 | 0.93 | NDUFS8 (0.58) | CA12CA9CA1CA6CA7 | |
| SCHEMBL3989449 | 0.89 | KMT2A (0.67) | CA12CA9CA1CA6CA7 | |
| SCHEMBL3470469 | 0.87 | CA12 (0.54) | CA12CA9CA1CA6CA7 | |
| SCHEMBL712741 | 0.87 | NDUFS8 (0.57) | CA12CA9CA1CA6CA7 | |
| SCHEMBL12081709 | 0.87 | NDUFS8 (0.57) | CA12CA9CA1CA6CA7 | |
| SCHEMBL28529405 | 0.87 | NDUFS8 (0.57) | CA12CA9CA1CA6CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328907-B1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | DSM IP ASSETS BV (NL) | 2018-12-12 | — | — | EP | disclosed |
| CN-108348615-A | O/W type lotions | 日油株式会社 | 2018-07-31 | — | — | CN | disclosed |
| US-20180057803-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | DSM IP ASSETS B.V. (NL) | 2018-03-01 | — | — | US | disclosed |
| US-20160108383-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | DSM IP ASSETS B.V. (NL) | 2016-04-21 | — | — | US | disclosed |
| US-9238804-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them | DSM IP ASSETS B.V. (NL) | 2016-01-19 | — | — | US | disclosed |
| EP-2329032-B1 | Methods using polypeptides having hydrolase activity | BUNGE OILS INC (US) | 2014-04-30 | — | — | EP | disclosed |
| US-8709775-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them | DSM IP ASSETS B.V. (NL) | 2014-04-29 | — | — | US | disclosed |
| US-8541191-B2 | Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids | BUNGE OILS, INC. (US) | 2013-09-24 | — | — | US | disclosed |
| US-8465942-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them | BUNGE OILS, INC. (US) | 2013-06-18 | — | — | US | disclosed |
| US-8420342-B2 | Hydrolases, nucleic acids encoding them and methods to produce triglycerides | BUNGE OILS, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-20100129882-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | BUNGE OILS, INC. | 2010-05-27 | — | — | US | disclosed |
| WO-2010024924-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | BUNGE OILS, INC. (US) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010025395-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION (US) | 2010-03-04 | — | — | WO | disclosed |
| US-20100055234-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | BUNGE OILS, INC. | 2010-03-04 | — | — | US | disclosed |
| US-20100055085-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-6991914-B2 | Silent marker for an oil product and associated detection method | SK CORPORATION (KR) | 2006-01-31 | — | — | US | disclosed |
| US-20040092738-A1 | Silent mark for oil product and detection method thereto | SK ENERGY CO., LTD. (KR) | 2004-05-13 | — | — | US | disclosed |
| EP-1309572-A4 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK CORP (KR) | 2004-03-17 | — | — | EP | disclosed |
| EP-1309572-A1 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK Corporation (KR) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002004431-A1 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK CORPORATION (KR) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057803-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | PNLIP, NOTUM, LIPC | CA12 3275/4885CA9 2202/4885CA1 2643/4885 |
| US-20040092738-A1 | Silent mark for oil product and detection method thereto | NOTUM, SQLE, MSMO1 | CA12 2366/4885CA9 2100/4885CA1 3358/4885 |
| US-20160108383-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | PNLIP, NOTUM, LIPC | CA12 3275/4885CA9 2202/4885CA1 2643/4885 |
| US-20100055085-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | PNLIP, NOTUM, LIPC | CA12 3275/4885CA9 2202/4885CA1 2643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.